Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Chin Hur, M.D.

TitleAssistant Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
10th Floor
101 Merrimac St.
Boston MA 02114
Phone617/724-4445
Fax617/726-9414

 Mentoring 
 completed student projects
Cost-Effectiveness of Prophylactic Surgery for Duodenal Cancer in Familial Adenomatous Polyposis
Summer, 05/26/08 - 08/29/08

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ananthakrishnan AN, Korzenik JR, Hur C. Can Mucosal Healing Be a Cost-effective Endpoint for Biologic Therapy in Crohn's Disease? A Decision Analysis. Inflamm Bowel Dis. 2013 Jan; 19(1):37-44.
    View in: PubMed
  2. Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013 Mar 15; 119(6):1149-58.
    View in: PubMed
  3. Ladabaum U, Brill JV, Sonnenberg A, Shaheen NJ, Inadomi J, Wilcox CM, Park WG, Hur C, Pasricha PJ. How to value technological innovation: a proposal for determining relative clinical value. Gastroenterology. 2013 Jan; 144(1):5-8.
    View in: PubMed
  4. Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med. 2012 Nov 6; 157(9):611-20.
    View in: PubMed
  5. Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology. 2012 Oct; 143(4):917-26.e1.
    View in: PubMed
  6. Choi SE, Hur C. Screening and surveillance for Barrett's esophagus: current issues and future directions. Curr Opin Gastroenterol. 2012 Jul; 28(4):377-81.
    View in: PubMed
  7. Hur C, Choi SE, Rubenstein JH, Kong CY, Nishioka NS, Provenzale DT, Inadomi JM. The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology. 2012 Sep; 143(3):567-75.
    View in: PubMed
  8. Omer ZB, Ananthakrishnan AN, Nattinger KJ, Cole EB, Lin JJ, Kong CY, Hur C. Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):722-7.
    View in: PubMed
  9. Kong CY, Nattinger KJ, Hayeck TJ, Omer ZB, Wang YC, Spechler SJ, McMahon PM, Gazelle GS, Hur C. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev. 2011 Nov; 20(11):2450-6.
    View in: PubMed
  10. Ananthakrishnan AN, Hur C, Korzenik JR. Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci. 2012 Feb; 57(2):472-80.
    View in: PubMed
  11. Ananthakrishnan AN, Hur C, Juillerat P, Korzenik JR. Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol. 2011 Nov; 106(11):2009-17.
    View in: PubMed
  12. Ho W, Broughton DE, Donelan K, Gazelle GS, Hur C. Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population. AJR Am J Roentgenol. 2010 Aug; 195(2):393-7.
    View in: PubMed
  13. Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer. 2010 Jun 15; 116(12):2941-53.
    View in: PubMed
  14. Yeh JM, Ho W, Hur C. Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival. Gastrointest Endosc. 2010 Jul; 72(1):33-43.
    View in: PubMed
  15. Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010 Aug; 23(6):451-7.
    View in: PubMed
  16. Hur C, Hayeck TJ, Yeh JM, Richards EM, Richards EB, Spechler SJ, Gazelle GS, Kong CY. Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One. 2010; 5(3):e9483.
    View in: PubMed
  17. Huang ES, Turner BG, Fernandez-Del-Castillo C, Brugge WR, Hur C. Pancreatic cystic lesions: clinical predictors of malignancy in patients undergoing surgery. Aliment Pharmacol Ther. 2010 Jan 15; 31(2):285-94.
    View in: PubMed
  18. Huang ES, Gazelle GS, Hur C. Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci. 2010 Mar; 55(3):852-60.
    View in: PubMed
  19. Yachimski P, Lee RA, Tramontano A, Nishioka NS, Hur C. Secular trends in patients diagnosed with Barrett's esophagus. Dig Dis Sci. 2010 Apr; 55(4):960-6.
    View in: PubMed
  20. Greenblatt WH, Hur C, Knudsen AB, Evans JA, Chung DC, Gazelle GS. Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2677-84.
    View in: PubMed
  21. Hur C, Broughton DE, Kong CY, Ozanne EM, Richards EB, Truong T, Gazelle GS. Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci. 2009 Oct; 54(10):2207-14.
    View in: PubMed
  22. Pandharipande PV, Harisinghani MG, Ozanne EM, Specht MC, Hur C, Lee JM, Gazelle GS. Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol. 2008 Nov; 191(5):1308-19.
    View in: PubMed
  23. Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS. Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2008 Oct; 103(10):2432-42.
    View in: PubMed
  24. Yachimski P, Hur C. Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis. Dig Dis Sci. 2009 Apr; 54(4):701-11.
    View in: PubMed
  25. Yachimski P, Nishioka NS, Richards E, Hur C. Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol. 2008 Nov; 6(11):1206-11.
    View in: PubMed
  26. Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology. 2008 Jul; 248(1):169-78.
    View in: PubMed
  27. Yeh JM, Kuntz KM, Ezzati M, Hur C, Kong CY, Goldie SJ. Development of an empirically calibrated model of gastric cancer in two high-risk countries. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1179-87.
    View in: PubMed
  28. Hur C, Yachimski P. How useful is histologic confirmation of intestinal metaplasia in patients with long-segment Barrett's esophagus? Nat Clin Pract Gastroenterol Hepatol. 2008 Mar; 5(3):140-1.
    View in: PubMed
  29. Kaplan GG, Hur C, Korzenik J, Sands BE. Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2007 Dec; 26(11-12):1509-20.
    View in: PubMed
  30. Hur C. The Cost-Effectiveness of Virtual Colonoscopy and the Importance of Small Polyps. AGA Perspectives. 2007; 3(4):8-14.
  31. Choi MY, Lauwers GY, Hur C, Willett CG, Chung DC. Microsatellite instability is frequently observed in rectal cancer and influenced by neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys. 2007 Aug 1; 68(5):1584.
    View in: PubMed
  32. Hur C, Chung DC, Schoen RE, Gazelle GS. The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):237-44.
    View in: PubMed
  33. Hur C. Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow? Clin Gastroenterol Hepatol. 2007 Mar; 5(3):307-9.
    View in: PubMed
  34. Schoen RE, Hur C. What is the clinical importance of small polyps with regard to colorectal cancer screening? Nat Clin Pract Gastroenterol Hepatol. 2006 Sep; 3(9):488-9.
    View in: PubMed
  35. Hur C, Wittenberg E, Nishioka NS, Gazelle GS. Quality of life in patients with various Barrett's esophagus associated health states. Health Qual Life Outcomes. 2006; 4:45.
    View in: PubMed
  36. Siegel CA, Hur C, Korzenik JR, Gazelle GS, Sands BE. Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol. 2006 Aug; 4(8):1017-24; quiz 976.
    View in: PubMed
  37. Hur C, Chan AT, Tramontano AC, Gazelle GS. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs. Ann Pharmacother. 2006 Jun; 40(6):1052-63.
    View in: PubMed
  38. Pandharipande PV, Harisinghani MG, Specht MC, Hur C, Lee J, Gazelle GS . Staging MR Lymphangiography of the Axilla for Operable Breast Cancer: A Cost-Effectiveness Analysis. Oral Presentation at the Annual Meeting of the Radiological Society of North America, Chicago, IL Dec 2005. 2005.
  39. Hur C, Gazelle GS, Hsu EH, Halpern EF, Podolsky DK. The effect of prior colonic imaging on endoscopic productivity: potential impact of computed tomographic colonography. Clin Gastroenterol Hepatol. 2005 Nov; 3(11):1124-7.
    View in: PubMed
  40. Jo WS, Bandipalliam P, Shannon KM, Niendorf KB, Chan-Smutko G, Hur C, Syngal S, Chung DC. Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol. 2005 Oct; 3(10):1022-8.
    View in: PubMed
  41. Hur C, Nishioka NS, Gazelle GS. Two models better than one. Gut. 2005 Aug; 54(8):1204; author reply 1204.
    View in: PubMed
  42. Hur C, Wittenberg E, Nishioka NS, Gazelle GS. Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci. 2005 Jan; 50(1):116-25.
    View in: PubMed
  43. Hur C, Simon LS, Gazelle GS. Analysis of aspirin-associated risks in healthy individuals. Ann Pharmacother. 2005 Jan; 39(1):51-7.
    View in: PubMed
  44. Genen L, Hur C, Chung R, Gazelle GS . Cost-Effectiveness of Radio-Frequency Ablation for the Treatment of Primary Hepatocellular Carcinoma in Transplant Eligible Patients - A State-Transition Monte Carlo Decision Analysis. Oral Presentation at the Annual Meeting of the Radiological Society of North America, Chicago, IL, Dec 2004. 2004.
  45. Hur C, Gazelle GS, Zalis ME, Podolsky DK. An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology. 2004 Nov; 127(5):1312-21.
    View in: PubMed
  46. Hur C, Simon LS, Gazelle GS. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals. Cancer. 2004 Jul 1; 101(1):189-97.
    View in: PubMed
  47. Hur C, Chung DC, Hsu EH, Evans JA, Gazelle GS. The Optimal Management for Duodenal Polyposis in Familial Adenomatous Polyposis. 2004; 125(4).
  48. Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst. 2004 Feb 18; 96(4):316-25.
    View in: PubMed
  49. Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci. 2003 Jul; 48(7):1273-83.
    View in: PubMed
  50. Hur C, Gazelle GS. Screening First Degree Relatives of Patients with Celiac Disease. Gastroenterology. 2003; 124(4 supp):M2118.
  51. Hur C, Lembo A. Gaseousness and Indigestion. Conn's Current Therapy, Rakel RE, Bope ET. 2002.
  52. Zaman SZ, Hur C, Jones M, Krueger RF, Chavez N, Talley NJ, Lembo A. Concordance of Reflux Among Monozygotic and Dizygotic Twins. Gastroenterology. 2001; 120(5 supp):A2136.
  53. Hur C, Michetti P, Kelly C. Hp Eradication rates and symptoms in patients with proven peptic ulcer. American Journal of Gastroenterology. 2000; 95(9):2454.
  54. Suerbaum S, Hur C, Josehans C, Michetti P. Pathogenesis and virulence factors of Helicobacter pylori. Current Opinion in Gastroenterology. 1999; 15(s1):11-16.
  55. Hur C, Appel L, Coresh J. The impact of Angiotensin Converting Enzyme Inhibitor Therapy on renal function in Diabetics: Results of a meta-analysis. American Journal of Hypertension. 1995; 8(4 Part II):40A.
  56. Brown NA, Kovacs A, Lui CR, Hur C, Zaia JA, Mosley JW. Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV. Lancet. 1988 Nov 12; 2(8620):1146.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Hur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (180) concept(s)
_
Co-Authors
See all (25) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_